05/2022 AUA Annual Meeting (American Urological Association) May 13-16, 2022 New Orleans, LA
We seek to improve the current standards of care in the diagnosis and treatment of urologic disorders by developing and optimizing procedure specific devices.
Corporation established in April, 2017
Private financing closed in 2018, 2019, 2020, and 2021
URO-1 creates breakthrough solutions for office procedures in urology which improve outcome, patient experience and procedure efficiency.
To improve the current standards of care in the diagnosis and treatment of urologic disorders by creating and optimizing procedure specific instruments.
© 2021 URO-1 Inc. URO-1, Repris, Re4m, Rely, SUREcore, coreCARE and their respective logos are trademarks of URO-1 Inc. All other trademarks are the property of their respective holders. Repris Bladder Injection System: US patents 10,286,159; 10,456,164; 10,463,797; 10,953,159. China patent ZL 201890000398.0 SUREcore and coreCARE: Patents Pending
PN60004 Rev C